T-cell activation by unmasked HER2-TCE was negligible in the absence of HER2-expressing BT-474 tumor cells, demonstrating that monovalent engagement of CD3 was insufficient for activation (see Extended Data Fig. 2). Here, ERBB2 is linked to neoplasm.